Status:
COMPLETED
A Novel Device for Surveillance of Vascular Access Sites for Bleeding
Lead Sponsor:
Changi General Hospital
Conditions:
Dialysis; Complications
Wound Complication
Eligibility:
All Genders
21+ years
Brief Summary
Background Bleeding is often encountered after vascular access procedures for dialysis and fatal episodes of haemorrhage has been reported. A technological solution was sought to monitor for such rare...
Detailed Description
Background Post-procedural wound hemorrhage is a potential complication following any invasive procedure. In the setting of hemodialysis, with multiple repeated vascular access procedures performed o...
Eligibility Criteria
Inclusion
- Hospital inpatients planned for dialysis catheter insertion or removal, based on standard clinical care and indications as identified by the primary nephrologist-in-charge.
Exclusion
- Patients who declined participation, or
- Patients with no legal representatives who were unable to provide consent
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04285775
Start Date
March 1 2019
End Date
June 30 2020
Last Update
January 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changi General Hospital
Singapore, Singapore, 529889